Clinical Trial Update: Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating post-transplant cyclophosphamide and sirolimus after reduced-intensity conditioning allogeneic transplantation for hematologic neoplasm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Hematologic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-03-17